Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas

  • Authors:
    • Levent Dizdar
    • Monika Tomczak
    • Thomas A. Werner
    • Sami A. Safi
    • Jasmin C. Riemer
    • Pablo E. Verde
    • Nikolas H. Stoecklein
    • Wolfram T. Knoefel
    • Andreas Krieg
  • View Affiliations

  • Published online on: September 19, 2017     https://doi.org/10.3892/ol.2017.6999
  • Pages:6847-6856
Metrics: PDF 0 views | HTML 0 views
0

Abstract

There is considerable evidence that the inhibitor of apoptosis protein (IAP) family serves a role in tumorigenesis. The most studied IAP family members, survivin and X‑linked inhibitor of apoptosis (XIAP), have been demonstrated to serve as biomarkers in distinct tumor entities. Thus, the present study aimed to investigate the expression levels of both IAPs in the tumor center, invasion front and lymph node metastases of surgically resected gastric cancer (GC) specimens. Tissue microarrays containing samples from 201 primary GCs were analyzed. IAP expression was detected using immunohistochemistry in different tumor compartments, normal mucosa and lymph node metastases. In addition, the association between the expression levels of these proteins, and clinicopathological parameters and overall survival was investigated. High levels of survivin and XIAP were evident in GC, when compared with normal mucosa, and were correlated with intestinal‑type and well‑differentiated GC, as well as low International Union Against Cancer stages. Increased XIAP expression was detected in lymph node metastases as compared with corresponding primary tumors. XIAP overexpression was identified to be an independent negative prognostic marker in diffuse and mixed type GC. These results suggest a potential role of survivin and XIAP in the early phase of gastric carcinogenesis. In addition, increased XIAP expression in lymph node metastases supports the observation that IAPs serve an essential role in metastatic tumor disease. Since XIAP expression was identified to be associated with poor survival in diffuse and mixed type GC, XIAP may serve as a novel therapeutic target in these types of GC.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Dizdar, L., Tomczak, M., Werner, T.A., Safi, S.A., Riemer, J.C., Verde, P.E. ... Krieg, A. (2017). Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas. Oncology Letters, 14, 6847-6856. https://doi.org/10.3892/ol.2017.6999
MLA
Dizdar, L., Tomczak, M., Werner, T. A., Safi, S. A., Riemer, J. C., Verde, P. E., Stoecklein, N. H., Knoefel, W. T., Krieg, A."Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas". Oncology Letters 14.6 (2017): 6847-6856.
Chicago
Dizdar, L., Tomczak, M., Werner, T. A., Safi, S. A., Riemer, J. C., Verde, P. E., Stoecklein, N. H., Knoefel, W. T., Krieg, A."Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas". Oncology Letters 14, no. 6 (2017): 6847-6856. https://doi.org/10.3892/ol.2017.6999